Pretreatment of colon carcinoma cells with tomudex enhances 5- fluorouracil cytotoxicity

Giuseppe S.A. Longo, Julie Izzo, Yu Ming Chang, William P. Tong, Zbigniev Zielinski, Richard Gorlick, Ting Chao Chou, Joseph R. Bertino

Research output: Contribution to journalArticlepeer-review

39 Scopus citations


The cytotoxic effect of sequence and dose of Tomudex (TX) and 5- fluorouracil (FUra) on an HCT-8 colon carcinoma cell line using a clonogenic assay was evaluated. Synergistic cell kill was obtained with 24 h of exposure to TX followed by 4 h of exposure to FUra. Marginal synergy was obtained with the same sequence but with a 5-day exposure to FUra. The reverse sequence, FUra (either 4 h or 5 days), followed by TX (24 h), resulted in less-than- additive cell kill. The synergistic effect was not due to augmented inhibition of thymidylate synthase, as determined by the measurement of thymidylate synthase activity by tritium release from [5-3H]2'-deoxyuridine. Surprisingly, an increase in intracellular levels of phosphoribosylpyrophosphate was observed after 24 h of exposure to TX, suggesting the possibility of an indirect effect of TX and/or its polyglutamates on purine biosynthesis. Moreover, we observed an increased formation of FUra nucleotides in the cells preexposed to TX, likely due to the increased intracellular levels of phosphoribosylpyrophosphate, that as a consequence led to an enhanced incorporation of FUra into RNA and increased cell killing.

Original languageEnglish (US)
Pages (from-to)469-473
Number of pages5
JournalClinical Cancer Research
Issue number2
StatePublished - Feb 1998
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Pretreatment of colon carcinoma cells with tomudex enhances 5- fluorouracil cytotoxicity'. Together they form a unique fingerprint.

Cite this